Anthem Bioscienc

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "768.40",
    "chg": 7.5,
    "chgp": "0.99%",
    "dir": 1,
    "prev_price": "760.90",
    "mcapval": "43,033.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "3.22 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-by-marketsmojo-3975778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3975778.png",
        "date": "2026-05-05 10:10:17",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-3960639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3960639.png",
        "date": "2026-04-24 10:10:16",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026."
      },
      {
        "title": "Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-upgraded-to-hold-on-technical-and-financial-reassessment-3944217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3944217.png",
        "date": "2026-04-13 08:26:55",
        "description": "Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting a notable improvement in technical indicators alongside steady fundamental performance despite recent quarterly setbacks. The mid-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 50.0, signalling a more balanced outlook for investors amid mixed financial trends and valuation concerns."
      },
      {
        "title": "Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-gains-1228-6-key-factors-driving-the-weeks-momentum-3942185",
        "imagepath": "",
        "date": "2026-04-11 09:02:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Mojo Grade downgraded to Sell amid technical and financial weakness</p>\n                    <p><strong>7 Apr:</strong> Technical momentum shifts to sideways trend with mixed signals</p>\n                    <p><strong>8 Apr:</strong> Mildly bullish momentum emerges with technical upgrades</p>\n                    <p><strong>9 Apr:</strong> Intraday high of ₹728.5 with a 5.83% surge</p>\n                    <p><strong>9 Apr:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>10 Apr:</strong> Technical momentum shifts to mildly bullish with strong price gains</p>\n                </div>\n\n                <div class=\"stats-row\">..."
      },
      {
        "title": "Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-gains-3941032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_technicaldot_3941032.png",
        "date": "2026-04-10 08:04:36",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term."
      },
      {
        "title": "Anthem Biosciences Ltd Surges 5.83% to Day's High of Rs 728.5 — Outperforms Sector by 4.93 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-hits-intraday-high-with-strong-583-surge-3939674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_priceRelatedfactors_3939674.png",
        "date": "2026-04-09 12:16:15",
        "description": "The Sensex declined by 0.68% on 09 Apr 2026, while Anthem Biosciences Ltd surged 5.83%, outperforming its Pharmaceuticals &amp; Biotechnology sector by nearly 5 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weak market backdrop."
      },
      {
        "title": "Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3938906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_technicaldot_3938906.png",
        "date": "2026-04-09 08:07:15",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite a 3.39% gain on 9 Apr 2026, the stock’s technical indicators present a complex picture, signalling caution for investors amid mixed signals from MACD, RSI, and moving averages."
      },
      {
        "title": "Anthem Biosciences Ltd Shows Mildly Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-shows-mildly-bullish-momentum-amid-technical-upgrades-3936524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_technicaldot_3936524.png",
        "date": "2026-04-08 08:04:27",
        "description": "Anthem Biosciences Ltd has shifted from a sideways technical trend to a mildly bullish stance, supported by key momentum indicators such as the MACD and Bollinger Bands. Despite a modest day change of 0.43%, the stock’s technical parameters suggest a cautiously optimistic outlook amid a challenging broader market environment."
      },
      {
        "title": "Anthem Biosciences Ltd Downgraded to Sell Amid Technical and Financial Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-downgraded-to-sell-amid-technical-and-financial-weakness-3935866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3935866.png",
        "date": "2026-04-07 08:50:22",
        "description": "Anthem Biosciences Ltd has seen its investment rating downgraded from Hold to Sell as of 6 April 2026, reflecting a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns. The mid-cap pharmaceutical and biotechnology firm’s Mojo Score has declined to 40.0, signalling caution for investors amid sideways technical trends and weakening profitability metrics."
      }
    ],
    "total": 29,
    "sid": "10039665",
    "stock_news_url": "https://www.marketsmojo.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Anthem Biosciences Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>U24233KA2006PLC039703</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>2.96</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Divya Prasad <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: divya.p@anthembio.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Mohammed Gawir Baig <br/> Designation: Chief Financial Officer <br/> EmailId: gawir.b@anthembio.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of LODR-Update In The Outcome Of The Board Meeting Held On April 22 2026",
      "datetime": "22-Apr-2026",
      "details": "Submission of the Outcome of the Board Meeting held on April 22 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
      "datetime": "22-Apr-2026",
      "details": "Submission of approval by the Board of Directors the appointment of M/s. S.R. Batliboi & Associates LLP as the Statutory Auditors of the Company at its Meeting held on April 22 2026 subject to the approval of the Shareholders.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd is Rated Hold by MarketsMOJO

2026-05-05 10:10:17

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Anthem Biosciences Ltd is Rated Hold

2026-04-24 10:10:16

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026.

Read full news article

Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment

2026-04-13 08:26:55

Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting a notable improvement in technical indicators alongside steady fundamental performance despite recent quarterly setbacks. The mid-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 50.0, signalling a more balanced outlook for investors amid mixed financial trends and valuation concerns.

Read full news article

Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum

2026-04-11 09:02:37

Key Events This Week

6 Apr: Mojo Grade downgraded to Sell amid technical and financial weakness

7 Apr: Technical momentum shifts to sideways trend with mixed signals

8 Apr: Mildly bullish momentum emerges with technical upgrades

9 Apr: Intraday high of ₹728.5 with a 5.83% surge

9 Apr: Technical momentum shifts amid mixed market signals

10 Apr: Technical momentum shifts to mildly bullish with strong price gains

...

Read full news article

Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains

2026-04-10 08:04:36

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term.

Read full news article

Anthem Biosciences Ltd Surges 5.83% to Day's High of Rs 728.5 — Outperforms Sector by 4.93 Percentage Points

2026-04-09 12:16:15

The Sensex declined by 0.68% on 09 Apr 2026, while Anthem Biosciences Ltd surged 5.83%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 5 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Read full news article

Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-04-09 08:07:15

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite a 3.39% gain on 9 Apr 2026, the stock’s technical indicators present a complex picture, signalling caution for investors amid mixed signals from MACD, RSI, and moving averages.

Read full news article

Anthem Biosciences Ltd Shows Mildly Bullish Momentum Amid Technical Upgrades

2026-04-08 08:04:27

Anthem Biosciences Ltd has shifted from a sideways technical trend to a mildly bullish stance, supported by key momentum indicators such as the MACD and Bollinger Bands. Despite a modest day change of 0.43%, the stock’s technical parameters suggest a cautiously optimistic outlook amid a challenging broader market environment.

Read full news article

Anthem Biosciences Ltd Downgraded to Sell Amid Technical and Financial Weakness

2026-04-07 08:50:22

Anthem Biosciences Ltd has seen its investment rating downgraded from Hold to Sell as of 6 April 2026, reflecting a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns. The mid-cap pharmaceutical and biotechnology firm’s Mojo Score has declined to 40.0, signalling caution for investors amid sideways technical trends and weakening profitability metrics.

Read full news article

View All News